First results from the BioCer clinical trial presented by Dr. Tronvik

The BioCer clinical trial has reached a major milestone with the completion of its primary phase.

The BioCer clinical trial was officially finalized at the end of 2024, marking an important step in the evaluation of this new treatment approach. The primary endpoint from the trial was presented at the 18th European Headache Congress, hosted by the European Headache Federation, which took place in Rotterdam from December 4th to 7th, 2024.

The results were presented by Dr. Tronvik from St. Olavs Hospital and NTNU, drawing considerable attention and interest from the audience. The presentation highlighted key findings from the trial and generated valuable discussion among clinicians and researchers in the field of headache and neurological disorders.

Further announcements based on the full clinical trial outcomes will be shared through scientific journals and official press releases over the coming months.